Literature DB >> 11148593

The National Marrow Donor Program. Meeting the needs of the medically underserved.

D L Confer1.   

Abstract

BACKGROUND: The National Marrow Donor Program operates the world's largest registry of volunteer unrelated stem cell donors. In recent years, the program has focused on building a large and diverse donor file. After initial recruitment, however, months or years may elapse before a potential donor is contacted on behalf of a searching patient. Here, the author begins to explore factors that influence donor availability at the confirmatory typing stage of the search process.
METHODS: Over a 1-year period from March 1, 1999 through February 29, 2000, the author evaluated donor unavailability rates at the confirmatory typing stage of the search process. Unavailability rates by donor racial/ethnic group and by donor center were evaluated. To determine the consistency within individual donor centers, the author compared donor unavailability during the first 6 months of the observation period with unavailability during the second 6 months.
RESULTS: Donor unavailability at confirmatory typing was higher among donors registered with domestic (U.S.) donor centers. The self-identified racial or ethnic group of the donor also affected the likelihood the donor will be available when requested. Between individual donor centers, there were large differences in the overall donor unavailability. Rates of donor unavailability tended to remain consistent at individual centers over time.
CONCLUSIONS: This study suggests that procedures used at individual donor centers may dramatically impact donor unavailability. Future initiatives should undertake to identify best practice models for donor recruitment, retention, and subsequent contacts. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11148593     DOI: 10.1002/1097-0142(20010101)91:1+<274::aid-cncr18>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation.

Authors:  Jeffrey K Davies; Lee M Nadler; Eva C Guinan
Journal:  Sci Transl Med       Date:  2009-10-07       Impact factor: 17.956

2.  Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide.

Authors:  Ashley T Munchel; Yvette L Kasamon; Ephraim J Fuchs
Journal:  Best Pract Res Clin Haematol       Date:  2011-07-13       Impact factor: 3.020

3.  Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

Authors:  Juliet N Barker; Courtney E Byam; Nancy A Kernan; Sinda S Lee; Rebecca M Hawke; Kathleen A Doshi; Deborah S Wells; Glenn Heller; Esperanza B Papadopoulos; Andromachi Scaradavou; James W Young; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-25       Impact factor: 5.742

4.  Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.

Authors:  Stella M Davies; Dan Wang; Tao Wang; Muhkta Arora; Olle Ringden; Claudio Anasetti; Steven Pavletic; James Casper; Margaret L Macmillan; Jean Sanders; Donna Wall; Nancy A Kernan
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

Review 5.  New advances in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; John A Hansen
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

6.  Support of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donors.

Authors:  Alexander H Schmidt; Ute V Solloch; Daniel Baier; Alois Grathwohl; Jan Hofmann; Julia Pingel; Andrea Stahr; Gerhard Ehninger
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

7.  Biobanks for genomics and genomics for biobanks.

Authors:  Anne Cambon-Thomsen; Pascal Ducournau; Pierre-Antoine Gourraud; David Pontille
Journal:  Comp Funct Genomics       Date:  2003

8.  Toward an optimal global stem cell donor recruitment strategy.

Authors:  Alexander H Schmidt; Jürgen Sauter; Julia Pingel; Gerhard Ehninger
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

Review 9.  Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).

Authors:  Alexander H Schmidt; Jürgen Sauter; Daniel M Baier; Jessica Daiss; Andreas Keller; Anja Klussmeier; Thilo Mengling; Gabi Rall; Tobias Riethmüller; Gerhard Schöfl; Ute V Solloch; Tigran Torosian; David Means; Helen Kelly; Latha Jagannathan; Patrick Paul; Anette S Giani; Sabine Hildebrand; Stephan Schumacher; Jan Markert; Monika Füssel; Jan A Hofmann; Thomas Schäfer; Julia Pingel; Vinzenz Lange; Johannes Schetelig
Journal:  Int J Immunogenet       Date:  2020-01-06       Impact factor: 1.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.